Owusu Boahen

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 134 citations

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_EMalaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

Sélidji Todagbé Agnandji, Kwaku Poku Asante, John Lyimo et al. · The Journal of Infectious Diseases · 2010 · 76 citations

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye et al. · The Lancet Infectious Diseases · 2020 · 75 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye et al. · The Lancet Infectious Diseases · 2020 · 63 citations

Vaccination, Vaccine Safety, Vaccine Development +7

Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy

Kwaku Poku Asante, Livesy Abokyi, Charles Zandoh et al. · BMC Public Health · 2010 · 50 citations · Full text